These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15054459)

  • 1. Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology.
    Kricker A; Goumas C; Armstrong B
    Br J Cancer; 2004 Apr; 90(7):1382-5. PubMed ID: 15054459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.
    Carlson KL; Helvie MA; Roubidoux MA; Kleer CG; Oberman HA; Wilson TE; Pollak EW; Rochester AB
    AJR Am J Roentgenol; 1999 Feb; 172(2):313-7. PubMed ID: 9930774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
    Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
    Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
    Harvey JM; Sterrett GF; Frost FA
    Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small size ductal carcinoma in situ of the breast: predictors of positive margins after local excision.
    de Roos MA; Groote AD; Pijnappel RM; Post WJ; de Vries J; Baas PC
    Int Surg; 2006; 91(2):100-6. PubMed ID: 16774181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J; Treasure P; Duffy S
    J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of four-quadrant random sections in mastectomy specimens.
    Gupta D; Nath M; Layfield LJ
    Breast J; 2003; 9(4):307-11. PubMed ID: 12846866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
    Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N
    Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
    van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
    Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
    Evans WP; Starr AL; Bennos ES
    Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ.
    Bae MS; Moon WK; Cho N; Chang JM; Seo M; Park IA; Han W
    AJR Am J Roentgenol; 2013 Sep; 201(3):684-91. PubMed ID: 23971464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.
    Jacklyn G; Morrell S; McGeechan K; Houssami N; Irwig L; Pathmanathan N; Barratt A
    Breast; 2018 Feb; 37():170-178. PubMed ID: 28882419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ: computer-aided detection in screening mammography.
    Pai VR; Gregory NE; Swinford AE; Rebner M
    Radiology; 2006 Dec; 241(3):689-94. PubMed ID: 17053200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ.
    Obeng-Gyasi S; Ong C; Hwang ES
    Chin Clin Oncol; 2016 Jun; 5(3):32. PubMed ID: 27197512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
    Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
    J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.